Health Care & Life Sciences » Pharmaceuticals | Furen Pharmaceutical Group Industry Co. Ltd.

Furen Pharmaceutical Group Industry Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
387
431
458
4,958
5,725
6,234
Cost of Goods Sold (COGS) incl. D&A
241
258
244
3,174
3,555
3,678
Gross Income
146
173
214
1,784
2,170
2,555
SG&A Expense
99
133
157
784
1,017
1,213
EBIT
42
36
52
-
1,147
1,333
Unusual Expense
3
1
9
-
10
-
Non Operating Income/Expense
-
2
3
28
14
19
Interest Expense
24
21
19
202
216
251
Pretax Income
28
21
33
829
963
1,108
Income Tax
5
5
9
154
188
214
Equity in Affiliates
-
-
9
-
-
-
Consolidated Net Income
23
16
33
675
775
893
Net Income
20
12
28
349
392
889
Net Income After Extraordinaries
20
12
28
349
392
889
Net Income Available to Common
20
12
28
349
392
889
EPS (Basic)
0.11
0.07
0.16
0.00
0.94
1.42
Basic Shares Outstanding
178
178
178
177,593
417
627
EPS (Diluted)
0.11
0.07
0.16
0.00
0.94
1.42
Diluted Shares Outstanding
178
178
178
177,593
417
627
EBITDA
78
79
99
1,295
1,475
1,685
Other Operating Expense
5
4
4
9
5
9
Non-Operating Interest Income
-
1
1
13
8
6
Minority Interest Expense
4
4
5
326
383
5

About Furen Pharmaceutical Group Industry Co.

View Profile
Address
9/F, Furen Building
Zhengzhou Henan 450008
China
Employees -
Website http://www.shfuren.cn
Updated 07/08/2019
Furen Pharmaceutical Group Industry Co., Ltd. engages in the pharmaceutical manufacturing, wholesale, and retail business. Its main products are Chinese medicines. The company was founded in August 2006 and is headquartered in Zhengzhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.